ClinicalTrials.Veeva

Menu

The Prognostic Value of Human Papilloma Virus in Nasopharyngeal Carcinoma

R

Rambam Health Care Campus

Status

Unknown

Conditions

Nasopharyngeal Carcinoma

Study type

Observational

Funder types

Other

Identifiers

NCT04014738
0190-19-RMB-CTIL

Details and patient eligibility

About

It is well established that HPV infection has a casual and is a prognostic factor in several cancer types, including oropharynx. We wish to examine if HPV infection has a prognostic significance in nasopharyngeal carcinoma.

Enrollment

100 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • nasopharyngeal carcinoma patients treated in our institute between 2008-2018

Exclusion criteria

  • missing clinical data
  • 2nd Head and neck primary cancer
  • very locally advanced or distant metastatic nasopharyngeal carcinoma
  • Prior radiation therapy to the head and neck region

Trial contacts and locations

1

Loading...

Central trial contact

Eran S Fridman, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems